Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
1.160
+0.010 (0.87%)
At close: Apr 28, 2026, 4:00 PM EDT
1.170
+0.010 (0.86%)
After-hours: Apr 28, 2026, 7:10 PM EDT
Revelation Biosciences Employees
Revelation Biosciences had 9 employees as of December 31, 2024. The number of employees decreased by 1 or -10.00% compared to the previous year.
Employees
9
Change (1Y)
-1
Growth (1Y)
-10.00%
Revenue / Employee
n/a
Profits / Employee
-$1,651,686
Market Cap
4.32M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9 | -1 | -10.00% |
| Dec 31, 2023 | 10 | 4 | 66.67% |
| Dec 31, 2022 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| AIM ImmunoTech | 21 |
| VivoSim Labs | 14 |
| Ensysce Biosciences | 10 |
| Dermata Therapeutics | 9 |
| Artelo Biosciences | 7 |
| Alzamend Neuro | 6 |
| Galmed Pharmaceuticals | 6 |
| 60 Degrees Pharmaceuticals | 3 |
REVB News
- 22 days ago - Revelation Biosciences Announces Formation of Acute Kidney Injury Advisory Board - Accesswire
- 4 weeks ago - Revelation Biosciences Inc. Presents Additional Positive Data from Prime Clinical Study - Accesswire
- 5 weeks ago - REMINDER: Revelation Biosciences to Host Fireside Chat at 38th Annual Roth Conference - Accesswire
- 5 weeks ago - Revelation Biosciences to Host Fireside Chat at 38th Annual Roth Conference - Accesswire
- 2 months ago - Revelation Biosciences, Inc. Announces Financial Results For the Three and Twelve Months Ended December 31, 2025 - Accesswire
- 3 months ago - Revelation Biosciences Inc. Announces 1-for-4 Reverse Stock Split Effective January 28, 2026 - Accesswire
- 3 months ago - Revelation Biosciences Inc. Announces Exercise of Warrants for $11 Million in Gross Proceeds - Accesswire
- 3 months ago - Revelation Biosciences Reaches Agreement with FDA on Gemini Approval Pathway for AKI - Accesswire